Edition:
United States

BioScrip Inc (BIOS.O)

BIOS.O on Nasdaq

1.12USD
2 Dec 2016
Change (% chg)

$0.01 (+0.90%)
Prev Close
$1.11
Open
$1.11
Day's High
$1.16
Day's Low
$1.10
Volume
1,210,209
Avg. Vol
998,313
52-wk High
$3.43
52-wk Low
$1.10

Latest Key Developments (Source: Significant Developments)

Bioscrip files for offering of up to 3.75 mln shares of common stock by the selling stockholder
Tuesday, 11 Oct 2016 06:06am EDT 

Bioscrip Inc :Files for offering of up to 3.75 million shares of common stock by the selling stockholder - sec filing.  Full Article

Bioscrip And Home Solutions enter deal to expedite closing
Friday, 2 Sep 2016 04:05pm EDT 

Press Release : Bioscrip and home solutions enter into amended asset purchase agreement to expedite closing . Co, hs infusion holdings inc further amended terms of their asset purchase agreement dated june 13, 2016 .Amended agreement to eliminate condition to closing that co receive stockholder approval to increase authorized share capital.  Full Article

Bioscrip enters into a tax asset protection plan
Friday, 12 Aug 2016 06:50am EDT 

Bioscrip Inc : Tax asset protection plan to protect company's ability to "utilize its net operating loss carryforwards" which total approximately $275 million . Bioscrip enters into a tax asset protection plan to protect its valuable tax assets . Will distribute to stockholders non-taxable dividend distribution of 1 preferred stock purchase right for each share of common stock of Co .Tax asset protection plan intended to act as "deterrent" to any person acquiring beneficial ownership of 4.9% or more of Co's common stock.  Full Article

North Tide Capital Master reports a passive stake of 7.5 pct in Bioscrip Inc
Monday, 27 Jun 2016 04:08pm EDT 

Bioscrip Inc :North Tide Capital Master LP reports a passive stake of 7.5 percent in Bioscrip Inc as of June 17, 2016 - SEC filing.  Full Article

BioScrip prices 40 mln shares offering at $2.00 per share
Thursday, 16 Jun 2016 10:20pm EDT 

BioScrip Inc : Says offering of 40.0 million common shares priced at $2.00 per share . Says expects to receive approximately $73.38 million in net proceeds from offering after deducting underwriting discounts .BioScrip prices underwritten offering of common stock.  Full Article

BioScrip to acquire Home Solutions
Monday, 13 Jun 2016 06:02am EDT 

BioScrip Inc : Total transaction consideration of $85.0 million . Will acquire substantially all of assets and assume certain liabilities of Home Solutions and its subsidiaries . Deal includes additional contingent consideration in form of restricted stock units . Closing consideration will consist of $80.0 million payable in cash, subject to certain adjustments and $5.0 million in shares . BioScrip inc says upon completion of transaction, Daniel Greenleaf will become chief executive officer of BioScrip . Upon completion of transaction, Daniel Greenleaf will become chief executive officer of BioScrip and join company's board . Rick Smith, director and chief executive officer of BioScrip will become vice chairman of board of directors . Jeffrey Kreger, chief financial officer of BioScrip, will serve as combined company's chief financial officer . BioScrip will continue to be headquartered in Denver, Colorado and plans to maintain branches throughout United States . Transaction is anticipated to be financed through net proceeds from an equity offering . Jefferies LLC is acting as financial advisor to BioScrip . Houlihan Lokey is acting as financial advisor to Home Solutions .BioScrip announces transformative acquisition of Home Solutions that will enhance focus as home infusion leader.  Full Article

Bioscrip announces proposed public offering of common stock
Monday, 13 Jun 2016 06:00am EDT 

Bioscrip Inc : Commenced an underwritten public offering of its common stock .Bioscrip announces proposed public offering of common stock.  Full Article

BioScrip Inc reaffirms FY 2016 EBITDA Guidance
Wednesday, 4 Nov 2015 07:00am EST 

BioScrip Inc:Reaffirms FY 2016 Adjusted EBITDA Guidance of Between $50 Million - $60 Million.  Full Article

BioScrip announces steps to enhance Shareholder Value
Monday, 10 Aug 2015 07:02am EDT 

BioScrip Inc:Announces steps to enhance shareholder value.Says implementing $35 million - $40 million in total cost savings over the next 12 months.Says provides full year 2016 EBITDA guidance of $50 - $60 million on revenues of $730 - $760 million.Says announces sale of non-core PBM business.Says retains Jefferies to explore strategic alternatives.Says names Chris Luthin as chief operating officer; engages Scott davido as chief implementation officer.To sell its non-core PBM business to Procare Pharmacy benefit manager inc for $25 million in cash.Proceeds from PBM business sale are projected to be used to pay down debt and support working capital needs.Says implementing reductions of approximately 12% of the workforce which will result in $19 million in total savings.Workforce reductions are expected to be completed by the end of the third quarter of 2015.Consolidating corporate functions in the company's Eden Prairie, minnesota facility and closing the Elmsford ny office by December.  Full Article

BioScrip appoints Veteran Finance Executive Jeffrey M. Kreger as Chief Financial Officer
Monday, 27 Apr 2015 07:00am EDT 

BioScrip Inc:Says that Jeffrey M. Kreger will join the Company as Senior Vice President, Chief Financial Officer and Treasurer, effective April 27.  Full Article

BRIEF-Bioscrip reports third quarter 2016 financial results

* Bioscrip Inc- preliminary full year 2017 guidance is revenues in range of $940 million to $980 million